Danske Bank’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Danske Bank’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$8	–	1695
2024 Q3	$8	Buy	+2	New	+$11	﹤0.01%	1538

Other funds holding SEEL

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

VWWMG

Vermillion & White Wealth Management Group Phoenixville, Pennsylvania $174M AUM 15.31% 1-Year Est. Return

Danske Bank's SEEL Position: Q4 2024 in Review

Danske Bank sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2024, closing a stake of 2 shares — an estimated $8 sold.

Danske Bank first reported a position in SEEL in Q3 2024 and held it in 1 quarter. The position peaked at $8 in Q3 2024. 2 funds tracked by Wall St. Rank hold SEEL as of Q4 2024.

Danske Bank reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 2 Seelos Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $8.
Danske Bank first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Danske Bank's Seelos Therapeutics, Inc. Common Stock position peaked at $8 in Q3 2024.
2 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.